Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers
Akagi, Y.; Hashimoto, Y.; Takiyama, W.; Mukaida, H.; Murakami, Y.; Ito, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(12): 1993-1997
2004
ISSN/ISBN: 0385-0684 PMID: 15570927 Document Number: 570660
We reported concurrent chemoradiation for postoperative recurrent esophageal cancer patients with lymph node metastases and a pulmonary metastasis. From October 2001 to January 2004, we treated 6 consecutive patients with radiation and concurrent chemotherapy using daily low-doses of CDDP and UFT-E. Of the 6 patients, 4 (67%) had a complete response and 2 (33%) a partial response, yielding an overall response rate of 100% (6/6). Five patients are now alive without cancers, and 1 patient died with cancer. Concurrent chemoradiation using daily low-doses of CDDP and UFT-E is feasible and seems to offer good results for recurrent esophageal cancer patients.